Hyaluronic Acid Market is Expected to Reach USD 13.4 Billion by 2024 Hyaluronic Acid Market 2024

Hyaluronic Acid Market is expected to reach USD 13.4 billion by
2024: Radiant Insights, Inc
The global hyaluronic acid market is expected to reach USD 13.4 billion by 2024, according to a new
report. Factors such as increasing concern in population regarding chemicals, desire to get quick and
evident results, and shorter recovery time are high impact-rendering drivers of this market.
The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed
and developing regions. The growing geriatric population coupled with growing awareness about
antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The
efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base.
The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic
acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis
and it is projected that by 2040, the number will grow to 78 million. This can be anticipated as
exponential growth in demand for hyaluronic acid injections.
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hyaluronic-acidmarket-analysis-by-product-single-injection-three-injection-five-injection-by-applicationosteoarthritis-adhesive-prevention-drug-delivery-dermal-fillers-and-segment-forecasts-to-2020
Moreover, mounting number of obese people indicates the growing number of people suffering from
orthopedic disorders. There is no permanent cure for these disorders and treatment includes use of pain
killers. However, hyaluronic acid-based viscosupplements are seen as a possible cure or at least a better
option to joint pain.
Further Key Findings from the Study Suggest:
In 2015, dermal fillers dominated the application segment due to increasing awareness about the available
aesthetic procedures and approval of effective products by the FDA. For instance, in 2013, the U.S. FDA
approved hyaluronan-based facial fillers to be used in corrective measures, filling fine lines, and antiaging
procedures. These dermal fillers constitute a large share in these procedures and witnessed 8% growth in
the year 2014. Cosmetic surgeries market is booming with approximately 14 million minimally invasive
procedures being performed every year.
Pharmaceutical-grade hyaluronan holds the largest share in terms of raw material used for products. It is
available in a wide range of molecular weights and manufacturers also provide customized hyaluronic
acid, especially for research purposes.
In 2015, non-animal based hyaluronan held the largest share of the source segment. It is extracted from
recombinant bacteria and has uniform molecular weight; therefore, it is preferred for research purposes.
Furthermore, non-animal based hyaluronic acid is preferred as the raw material for the production of food
supplements. It eliminates the risk of cross-contamination and the varied molecular weight does not affect
the quality of the products.